V

Varian

Tech-enabled radiation oncology hardware and software

Vice President Finance - Multiple Teams

Full-TimePosted on 10/16/2026
$244k - $335.5k+ Commission
Expert
Bachelor's, MBA
Hoffman Estates, IL, USA
In Person
Finance & BankingCorporate Finance & FP&A
Company Historically Provides H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in business administration, Accounting, or Finance is required; an MBA is a plus.
  • At least 10 years of experience in business administration, including financial controlling and business-plan development, with experience working with Sales and/or Customer Services organizations.
  • Experience in healthcare is beneficial but not required; finance experience in Sales, CRM, or Customer Services is preferred.
  • Experience managing international cross-functional and cross-hierarchical teams and stakeholders.
  • Experience using digital tools, especially Jedox, and knowledge of SAP transactions.
  • Ability to serve as a trusted advisor and thought partner to senior business leaders.
  • Ability to work in a structured and independent manner with personal responsibility, build trust, and drive accountability.
  • Team orientation, decisiveness, and commitment, including collaboration across global and cross-functional teams.
  • Strong analytical skills, strategic and forward-thinking judgment, and execution discipline.
  • Ability to adapt leadership style to the situation to encourage the team.
  • Willingness to travel 20%.
  • Passion for healthcare and interest in helping shape its future.
  • Ability to work with controlled technology in accordance with United States export control law.
Responsibilities
  • Partner with the Molecular Imaging Marketing & Sales Head, Customer Services Head, and their respective leadership teams as a trusted advisor.
  • Manage financial Marketing & Sales activities, including market and competitive analytics, planning, and strategy planning, ensuring relevant information is available to support management decisions.
  • Support long-term business planning and coordinate global product and price positioning, service contract pricing, and new product launches with Marketing & Sales and Customer Services leadership.
  • Manage region- and zone-specific escalations and facilitate action plans across sales and service organizations.
  • Drive topline and gross-margin planning and forecasting with Marketing & Sales and Customer Services leadership across all regions.
  • Provide financial insights and recommendations to support strategic decisions, business growth initiatives, and operational excellence.
  • Lead a team of individuals across various regions.
  • Use digital tools, analytics, and business intelligence solutions to improve decision-making.
  • Manage investment planning and cost control for Marketing and Service activities.
  • Collaborate with Strategy, Logistics, PLM, and Procurement to provide input, analytics, transparency, and action plans for Molecular Imaging's long- and short-term goals.
  • Lead, develop, and inspire an international team of Marketing & Sales and Customer Services controlling professionals.
  • Foster continuous improvement through employee development, knowledge sharing, and personal responsibility, aligned with company values.
  • Build organizational capability through coaching, mentoring, and succession planning.
  • Promote cross-regional and cross-functional collaboration and sharing of best practices.
Desired Qualifications
  • Experience in healthcare.
  • Finance experience in Sales, CRM, or Customer Services.
  • An MBA.

About the company

Varian, part of Siemens Healthineers, focuses on oncology by providing integrated radiation oncology solutions that combine software, hardware, patient data, and care teams. Its offerings include treatment-planning software, radiation therapy machines, and data-management systems that work together to enable precise cancer treatments. The company differentiates itself through an integrated platform approach and services like Oncology-as-a-Service (OaaS), which lets healthcare providers adopt advanced radiation oncology with ongoing service support rather than large upfront investments. Varian serves healthcare providers such as hospitals and cancer centers, helping them deliver coordinated care and improve patient outcomes. Its goal is to reduce the fear of cancer by using data and technology to support clinicians in delivering effective treatments.

Company Size

5,001-10,000

Company Stage

IPO

Headquarters

Palo Alto, California

Founded

1948

Get referred to Varian

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • ARPA-H awarded Varian up to $60 million in April 2026 for FLASH-RT.
  • FDA cleared TrueBeam for osteoarthritis in March 2026, opening a non-cancer market.
  • Telix collaboration and 2026 AI approvals expand Varian's clinical and software pipeline.

What critics are saying

  • RaySearch enabled online adaptive TrueBeam workflows in Belgium in May 2026, eroding software differentiation.
  • Elekta still attacks Varian's lead in adaptive radiotherapy and premium MR-guided care.
  • If FLASH and non-oncology bets fail by 2028, Varian becomes a commoditized linear-accelerator vendor.

What makes Varian unique

  • Siemens Healthineers gives Varian imaging, radiotherapy, and capital-sales integration globally.
  • Varian's 2026 CE-marked Eclipse AI contouring deepens workflow lock-in across planning.
  • TrueBeam, Halcyon, and Ethos create an installed-base moat hospitals rarely replace.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Flexible Work Hours
  • Remote Work Options
  • Paid Vacation
  • Paid Holidays
  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Wellness Program
  • 401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Varex Imaging Corporation
Sep 14th, 2026
About Us | Varex Imaging Corporation

We strive to help customers become world-class system suppliers by strengthening their competitiveness and enabling them to bring products to market faster

MEDQOR
Apr 30th, 2026
Siemens Healthineers secures $83M to develop photon Flash radiotherapy for cancer treatment

Siemens Healthineers has received up to $60 million from the US Advanced Research Projects Agency for Health to develop photon Flash radiotherapy, with the company contributing an additional $23 million, totalling $83 million over five years. Flash photon therapy delivers radiotherapy more than 100 times faster than current technologies, aiming to reduce side effects and improve healthy tissue sparing. Unlike proton and electron beam platforms, which face scalability challenges, photon beams are the standard of care for over 50% of cancer patients. The project will build on existing C-arm linear accelerators to enable broader clinical access. Siemens Healthineers aims to transition ultra-high dose rate radiotherapy from experimental treatment into global standard of care within the five-year timeframe.

Business Wire
Mar 19th, 2026
Varian TrueBeam gets FDA clearance for low-dose radiotherapy to treat osteoarthritis

Siemens Healthineers has received FDA 510(k) clearance for its Varian TrueBeam radiotherapy systems to treat medically refractory osteoarthritis in adults using low-dose radiation therapy. This marks the first expansion of Varian's radiotherapy platform beyond cancer care into chronic musculoskeletal conditions. Osteoarthritis affects over 33 million adults in the US and approximately 600 million globally. The clearance covers TrueBeam, TrueBeam STx, VitalBeam and Edge systems, offering patients with persistent pain a non-invasive outpatient treatment option that targets inflammation, reduces pain and improves joint function. The approval builds on Varian's previous regulatory clearances for non-oncological indications, including radiosurgery treatment for medically refractory essential tremor. The TrueBeam platform combines high-resolution imaging with precise dose control whilst maintaining streamlined clinical workflows.

AuntMinnieEurope.com
Dec 10th, 2025
Telix and Varian enter research collaboration

Telix and Varian enter research collaboration. Telix Pharmaceuticals and Siemens Healthineers' company Varian have agreed to develop novel clinical applications that combine Telix's theranostics products and Varian's external beam radiation therapy (EBRT) technology. The first area of focus will be in identifying opportunities to use Telix's prostate cancer PET imaging agents in selecting patients for EBRT, developing personalized treatment plans (particularly in the context of Varian's Ethos adaptive radiotherapy system), and monitoring responses to treatment, Telix said. The agreement supports both company-sponsored and investigator-led clinical studies. Varian is a key player in EBRT and working with the company will allow Telix to explore how theranostics can be used more effectively by radiation oncologists to enhance patient selection and deliver targeted treatment, Telix noted. I agree to receive marketing related digital communications about products, services, events and offers that may be relevant to my given user preferences and behavior. I agree to share my information with the sponsor. I have read and agree to the privacy policy & terms of service and wish to opt-in.

AuntMinnie.com
Mar 28th, 2025
Varian, Embolx sign image-guided microcatheter agreement

Siemens Healthineers company Varian has entered into a sales and marketing agreement with Embolx for its Sniper Balloon Occlusion Microcatheter.